High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders.
Cavanna
L
L
Sbolli
G
G
Tanzi
E
E
Romanò
L
L
Civardi
G
G
Buscarini
E
E
Vallisa
D
D
Berté
R
R
Rossi
A
A
D015331:Cohort Studies; D015897:Comorbidity; D016174:Hepacivirus / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008232:Lymphoproliferative Disorders / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D012189:Retrospective Studies; D016036:Seroepidemiologic Studies
D018937:Hepatitis C Antibodies